• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性心脏病不会增加患严重 COVID-19 的风险。

Congenital heart disease does not entail an increased risk for severe COVID-19.

机构信息

Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

出版信息

Acta Paediatr. 2023 Feb;112(2):286-289. doi: 10.1111/apa.16588. Epub 2022 Nov 12.

DOI:10.1111/apa.16588
PMID:36330671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9877555/
Abstract

AIM

To analyse the risk of developing serious disease or death due to COVID-19 among patients who underwent heart surgery during childhood.

METHODS

A retrospective combined register and patient file study. We identified all individuals who had undergone surgery for congenital heart disease in childhood between 1994 and 2019 in our Local Surgical Register that covers half of the Swedish population. This effort was cross-tabulated with the diagnosis of COVID-19 entered in the National Register of Diagnoses in Sweden from 1 March 2020 to 1 March 2021. Severe disease was defined as treatment at an intensive care unit (ICU).

RESULTS

We identified 3950 individuals, and the median age at follow-up was 16 years (1-44). A total of 32 patients were diagnosed with COVID-19. Five of them were hospitalised for more than 2 days (5-32 days). Two adults required treatment at an ICU; both had additional comorbidity and one died. The corresponding number of ICU stays for this age range in Sweden was 2020 approximately 0.13/1000 person-years, reported from The Swedish Intensive Care Registry.

CONCLUSIONS

There was no increased rate of severe COVID-19 among individuals who had undergone surgery for congenital heart disease in childhood. Additional comorbidity is related to outcome.

摘要

目的

分析儿童期接受心脏手术的患者因 COVID-19 而患严重疾病或死亡的风险。

方法

回顾性联合登记和患者病历研究。我们在涵盖瑞典人口一半的本地手术登记处中,确定了在 1994 年至 2019 年间接受先天性心脏病手术的所有个体。这项工作与从 2020 年 3 月 1 日至 2021 年 3 月 1 日在瑞典国家诊断登记处输入的 COVID-19 诊断进行了交叉制表。严重疾病定义为在重症监护病房(ICU)接受治疗。

结果

我们确定了 3950 名个体,随访的中位年龄为 16 岁(1-44 岁)。共有 32 名患者被诊断出患有 COVID-19。其中 5 人因住院超过 2 天(5-32 天)。2 名成年人需要在 ICU 接受治疗;两者均有额外的合并症,其中 1 人死亡。在瑞典,该年龄组的 ICU 入住人数约为 2020 年 0.13/1000 人年,来自瑞典重症监护登记处报告。

结论

儿童期接受先天性心脏病手术的个体 COVID-19 严重感染率没有增加。额外的合并症与结果有关。

相似文献

1
Congenital heart disease does not entail an increased risk for severe COVID-19.先天性心脏病不会增加患严重 COVID-19 的风险。
Acta Paediatr. 2023 Feb;112(2):286-289. doi: 10.1111/apa.16588. Epub 2022 Nov 12.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
Congenital cardiac interventions during the peak phase of COVID-19 pandemics in the country in a pandemics hospital in Istanbul.在伊斯坦布尔一家传染病医院,该国新冠疫情高峰期的先天性心脏介入治疗。
Cardiol Young. 2020 Sep;30(9):1288-1296. doi: 10.1017/S1047951120002000. Epub 2020 Jul 2.
5
Clinical characteristics and outcomes of children with COVID-19 in Saudi Arabia.沙特阿拉伯新冠肺炎儿童患者的临床特征与转归
Saudi Med J. 2021 Apr;42(4):391-398. doi: 10.15537/smj.2021.42.4.20210011.
6
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.2020 年 12 月至 2021 年 5 月期间,在挪威报告的 SARS-CoV-2 变异株 B.1.1.7 和 B.1.351 与住院和重症监护入院风险增加相关。
PLoS One. 2021 Oct 11;16(10):e0258513. doi: 10.1371/journal.pone.0258513. eCollection 2021.
7
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
8
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.韩国2019冠状病毒病儿科患者的特征。
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
9
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
10
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.恢复期血浆/甲磺酸卡莫司他用于早期SARS-CoV-2 Q-PCR阳性高危个体(RES-Q-HR):一项随机对照试验研究方案的结构化总结
Trials. 2021 May 17;22(1):343. doi: 10.1186/s13063-021-05181-0.

引用本文的文献

1
Clinical risk associated with COVID-19 among 86000 patients with congenital heart disease.86000 例先天性心脏病患者 COVID-19 相关临床风险。
Open Heart. 2023 Dec 14;10(2):e002415. doi: 10.1136/openhrt-2023-002415.
2
COVID-19 and heart disease in children: What have we learned?儿童的新冠病毒疾病与心脏病:我们了解到了什么?
Ann Pediatr Cardiol. 2023 Mar-Apr;16(2):81-86. doi: 10.4103/apc.apc_104_23. Epub 2023 Aug 16.

本文引用的文献

1
COVID-19 trends and severity among symptomatic children aged 0-17 years in 10 European Union countries, 3 August 2020 to 3 October 2021.2020 年 8 月 3 日至 2021 年 10 月 3 日,10 个欧盟国家 0-17 岁有症状儿童的 COVID-19 趋势和严重程度。
Euro Surveill. 2021 Dec;26(50). doi: 10.2807/1560-7917.ES.2021.26.50.2101098.
2
Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: A multicentric study from India.新冠病毒检测呈阳性的患心脏病儿童及患先天性心脏病成人的预后:一项来自印度的多中心研究。
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):269-277. doi: 10.4103/apc.apc_134_21. Epub 2021 Aug 26.
3
Worse Hospital Outcomes for Children and Adults with COVID-19 and Congenital Heart Disease.COVID-19 合并先天性心脏病患儿和成人的预后更差。
Pediatr Cardiol. 2022 Mar;43(3):541-546. doi: 10.1007/s00246-021-02751-6. Epub 2021 Oct 11.
4
Characteristics and outcomes of acute COVID-19 infection in paediatric and young adult patients with underlying cardiac disease.患有基础心脏疾病的儿科和青年患者急性 COVID-19 感染的特征和结局。
Cardiol Young. 2022 Aug;32(8):1261-1267. doi: 10.1017/S1047951121004029. Epub 2021 Sep 30.
5
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.与儿童 COVID-19 重症相关的基础医学状况。
JAMA Netw Open. 2021 Jun 1;4(6):e2111182. doi: 10.1001/jamanetworkopen.2021.11182.
6
COVID-19 in Adults With Congenital Heart Disease.成人先天性心脏病患者中的 COVID-19。
J Am Coll Cardiol. 2021 Apr 6;77(13):1644-1655. doi: 10.1016/j.jacc.2021.02.023.
7
Clinical outcome of COVID-19 in patients with adult congenital heart disease.成人先天性心脏病患者感染新型冠状病毒肺炎的临床结局
Heart. 2021 Jul 12;107(15):1226-1232. doi: 10.1136/heartjnl-2020-318467.
8
Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City.2019 年冠状病毒病(COVID-19)对全生命周期先天性心脏病患者的影响:纽约市一家学术先天性心脏病中心的经验。
J Am Heart Assoc. 2020 Dec;9(23):e017580. doi: 10.1161/JAHA.120.017580. Epub 2020 Oct 14.
9
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.唐氏综合征患者的新冠病毒病死亡风险:一项针对800万成年人的队列研究结果
Ann Intern Med. 2021 Apr;174(4):572-576. doi: 10.7326/M20-4986. Epub 2020 Oct 21.
10
Pediatric Patients with SARS-CoV-2 Infection: Clinical Characteristics in the United States from a Large Global Health Research Network.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的儿科患者:来自大型全球健康研究网络的美国临床特征
Cureus. 2020 Sep 12;12(9):e10413. doi: 10.7759/cureus.10413.